The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT), is accepting applications for fiscal year (FY) 2017 Targeted Capacity Expansion: Medication Assisted Treatment - Prescription Drug and Opioid Addiction (MAT-PDOA) grants. The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder seeking or receiving MAT. This program targets states identified with having the highest rates of primary treatment admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and opioids, based on SAMHSA’s Treatment Episode Data Set (TEDS): 2007 – 2014. The desired outcomes include:
- An increase in the number of admissions for MAT;
- An increase in the number of clients receiving integrated care/treatment;
- A decrease in illicit opioid drug use at six-month follow-up; and
- A decrease in the use of prescription opioids in a non-prescribed manner at six-month follow-up.
Applications are due Monday, July 31, 2017. For more information, please click here.
No download available
Popular TopicsTreatment Substance abuse Drug treatment Drug use Drug abuse
- Comparing person-level matching algorithms to identify risk across disparate datasets among patients with a controlled substance prescription: retrospective analysis
- Privacy, Civil Rights, and Civil Liberties Policy Development Template for State, Local, Tribal, and Territorial (SLTT) Justice Entities Policy Review Checklist
- The Current Community Context of Overdose Deaths: Relations among Drug Types, Drug Markets, and Socioeconomic Neighborhood Characteristics